VC firm
Jazz Venture Partners
Also known as JAZZ Human Performance, JAZZ Human Performance Fund II A, JAZZ Human Performance Fund II, LP, JAZZ Human Performance Fund II-A, LLC, JAZZ Human Performance Fund III, LP, JAZZ Human Performance Growth, JAZZ Human Performance Growth Opportunity Fund II, LP, JAZZ Human Performance Opportunity Fund, LP
- Investor type
- VC
- Headquarters
- SAN FRANCISCO, CA, United States
- Assets under management
- $1.1BForm ADV private fund GAV, as of 2026-03-31Source (opens in a new tab)
- Latest fund size
- $548MForm ADV gross asset value, as of 2020Source (opens in a new tab)
- Funds
- 8
- Legal name
- JAZZ VENTURE PARTNERS, LLC
Claim, correct or request removal
Record updated 29 September 2026
About
We are a team of experienced operators, technologists, scientists, and entrepreneurs who work together to make a positive difference.
Investment approach
- Thesis
- JAZZ seeks breakthroughs at the convergence of technology, science, and humanity — improving how we live, work, and experience the world.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Andrew serves on the boards of several technology, health, consumer, and enterprise companies in the JAZZ portfolio, including AllStripes, Blue Note Therapeutics, Cadence Neuroscience, Embodied, Magnus Medical, Mahana Therapeutics, Thrive Global, Woebot, Yumi, and Zus.
Funds
- JAZZ Human Performance Fund II-A, LLC
- $11.6MVintage 2021, SPV, SEC amount sold
- JAZZ Human Performance Growth Opportunity Fund II, LP
- Vintage 2021Main fund
- JAZZ Human Performance Fund III, LP
- Vintage 2020Main fund
- JAZZ Human Performance Fund II, LP
- $287MVintage 2018, Main fund, SEC amount sold
- JAZZ Human Performance Opportunity Fund, LP
- $19.2MVintage 2018, Main fund, SEC amount sold
- JAZZ HUMAN PERFORMANCE TECHNOLOGY FUND, LP
- Main fund
- WINDWARD HUMAN PERFORMANCE-A LLC
- Main fund
- JAZZ HUMAN PERFORMANCE FUND II-B, LLC
- Main fund
SEC registration
- Registered adviser
- JAZZ VENTURE PARTNERS, LLC
- CRD number
- 277092 (opens in a new tab)
- SEC file number
- 802-106693
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $1.1Bas of 2026-03-31
- Private funds reported
- 6
- Principal office
- SAN FRANCISCO, CA, United States
- SEC CIK
- 1740003, 1762297, 1828844
Loading relationship preview